Enfusion Inc. (ENFN)
NYSE: ENFN
· Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM
Enfusion Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.92M | 4.38M | 4.59M | 3.76M | 8.99M | 9.14M | 9.08M | 3.96M | -13.26M | -307.94M | -307.25M | -298.88M | -282.24M | -535K | 1.75M | 2.84M |
Depreciation & Amortization | 11.75M | 10.62M | 10.18M | 9.39M | 8.59M | 8.16M | 7.34M | 6.87M | 6.34M | 5.97M | 5.26M | 4.56M | 3.98M | 3.33M | 2.95M | 2.38M |
Stock-Based Compensation | 19.03M | 18.7M | 17.13M | 15.61M | 7.46M | 8.26M | 6.07M | 11.16M | 24.99M | 310.59M | 310.15M | 302.49M | 289.8M | n/a | n/a | n/a |
Other Working Capital | -2.53M | -3.72M | -5.29M | -8.01M | -5.77M | -8.44M | -7.49M | -4.62M | 1.72M | 2.93M | 19.42M | 20.98M | 17.48M | 40.62M | 39.65M | 35.39M |
Other Non-Cash Items | 37.18M | 47.2M | 48.23M | 32.74M | 17.96M | 6.14M | 4.95M | 1.66M | 1.35M | 299.97M | 299.34M | 299.49M | 299.52M | 1.34M | 1.24M | 1.12M |
Deferred Income Tax | n/a | -10.07M | -9.29M | -9.07M | -9.07M | 993K | 213K | n/a | n/a | -296.63M | -296.63M | -296.63M | -296.63M | n/a | n/a | n/a |
Change in Working Capital | -7.87M | -11.06M | -15.12M | -13.57M | -9.44M | -6.13M | -5.35M | -4.81M | -5.6M | -11.46M | -20.52M | -16.21M | -14.74M | -9.55M | -2.74M | -7.04M |
Operating Cash Flow | 34.68M | 30.44M | 26.39M | 25.09M | 24.48M | 26.57M | 22.3M | 19.18M | 14.16M | 823K | -9.33M | -5.18M | -318K | -5.42M | 3.2M | -700K |
Capital Expenditures | -10.89M | -10.52M | -10.36M | -9.87M | -9.67M | -9.12M | -7.44M | -7.31M | -7.93M | -7.83M | -8.88M | -8.83M | -8.01M | -7.84M | -6.56M | -5.97M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -12.37M | -15.82M | -10.33M | -8.75M | -7.7M | -6.42M | -6.42M | -5.01M | -3.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -13.89M | -13.52M | -13.36M | -9.87M | -9.67M | -9.12M | -7.44M | -7.31M | -7.93M | -7.83M | -8.88M | -8.83M | -8.01M | -7.84M | -6.56M | -5.97M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -98.75M | -100M | -100M | -100M | 69.96M | 71.14M | 71.14M |
Common Stock Repurchased | n/a | -579K | -1.83M | -42.35M | -48.66M | -55.12M | -55.14M | -14.73M | -7.96M | -88.76M | -88.74M | -88.65M | -87.85M | -76.63M | -76.63M | -76.63M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.75M | -3.28M | -5.86M | -6.03M | -3.3M | -4.73M | -3.46M |
Other Financial Acitivies | -1.4M | -1.98M | -14.91M | -45.73M | -50.71M | -57.18M | -44.26M | -13.51M | -7.96M | 163.96M | 163.98M | 164.07M | 164.88M | -54.74M | -56.54M | -55.75M |
Financial Cash Flow | -1.4M | -831K | -6.13M | -36.95M | -41.93M | -49.55M | -44.26M | -13.51M | -7.96M | 62.47M | 60.7M | 58.21M | 58.85M | 11.92M | 9.87M | 11.92M |
Net Cash Flow | 18.88M | 16.65M | 6.68M | -21.7M | -26.94M | -31.89M | -28.79M | -1.61M | -1.82M | 55.11M | 42.04M | 44.08M | 50.43M | -1.4M | 6.51M | 5.18M |
Free Cash Flow | 23.79M | 19.92M | 16.03M | 15.22M | 14.81M | 17.45M | 14.87M | 11.87M | 6.22M | -7M | -18.2M | -14.02M | -8.33M | -13.26M | -3.36M | -6.67M |